Studies suggesting a link between GLP-1s and a small increased risk of the rare vision condition NAION (eye stroke) motivated the FDA action.
Need help?
Contact usStudies suggesting a link between GLP-1s and a small increased risk of the rare vision condition NAION (eye stroke) motivated the FDA action.